Do we need controlled attenuation parameter adjustment for fibrosis estimation in nonalcoholic fatty liver disease patients?
Thomas KarlasSebastian BeerJonas BabelHarald BusseAlexander SchaudinnNicolas LinderJohannes WiegandDavid PetroffPublished in: Hepatology (Baltimore, Md.) (2017)